Bacitracin resistance and enhanced virulence of Streptococcus suis via a novel efflux pump.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, 2005-
    • Subject Terms:
    • Abstract:
      Background: Streptococcus suis is a prominent pathogen causing septicemia and meningitis in swine and humans. Bacitracin is used widely as a growth promoter in animal feed and to control the spread of necrotic enteritis in most developing countries. This study aimed to characterize a novel membrane transporter module Sst comprising SstE, SstF, and SstG for bacitracin resistance.
      Results: Comparative genomics and protein homology analysis found a potential efflux pump SstFEG encoded upstream of well-known bacitracin-resistance genes bceAB and bceRS. A four-fold decrease in bacitracin susceptibility was observed in sstFEG deletion mutant comparing with S. suis wildtype strain CZ130302. Further studies indicated that the bacitracin tolerance mediated by SstFEG is not only independent of the BceAB transporter, but also regulated by the two-component system BceSR. Given that SstFEG are harbored by almost all virulent strains, but not in the avirulent strains, we managed to explore its potential role in bacterial pathogencity. Indeed, our results showed that SstFEG is involved in S. suis colonization and virulence in animal infection model by its potential competitive survival advantage against host bactericidal effect.
      Conclusion: To our knowledge, this is the first study to functionally characterize the bacitracin efflux pump in S. suis to provide evidence regarding the important roles of the novel ABC transporter system SstFEG with respect to drug resistance and virulence.
    • References:
      Clin Infect Dis. 2009 Mar 1;48(5):617-25. (PMID: 19191650)
      Am J Vet Res. 1989 Jul;50(7):1037-43. (PMID: 2774320)
      Genome Announc. 2017 Jan 19;5(3):. (PMID: 28104658)
      Antimicrob Agents Chemother. 2004 Oct;48(10):3743-8. (PMID: 15388429)
      RNA. 2014 Jun;20(6):882-98. (PMID: 24759092)
      Appl Environ Microbiol. 2018 Aug 31;84(18):. (PMID: 30030221)
      Mol Microbiol. 2016 May;100(4):607-20. (PMID: 26815905)
      J Infect Dis. 2009 Jan 1;199(1):97-107. (PMID: 19016627)
      Vet Microbiol. 2017 Jun;205:26-33. (PMID: 28622857)
      PLoS One. 2007 Mar 21;2(3):e315. (PMID: 17375201)
      Front Microbiol. 2011 Nov 25;2:235. (PMID: 22275909)
      Vet Microbiol. 2019 Feb;229:110-116. (PMID: 30642585)
      Genome Announc. 2013 Jun 27;1(3):null. (PMID: 23814033)
      Vet Res Commun. 1984 Aug;8(3):217-27. (PMID: 6495639)
      Vet Microbiol. 2013 Oct 25;166(3-4):595-601. (PMID: 23870707)
      PLoS One. 2015 Sep 16;10(9):e0137760. (PMID: 26375680)
      Antimicrob Agents Chemother. 2002 Dec;46(12):3756-64. (PMID: 12435673)
      Biomed Res Int. 2016;2016:6815894. (PMID: 28078298)
      Appl Environ Microbiol. 2015 Feb;81(3):976-85. (PMID: 25416757)
      BMC Genomics. 2011 Oct 25;12:523. (PMID: 22026465)
      J Biol Chem. 2005 Aug 12;280(32):28852-7. (PMID: 15946938)
      Vet Res. 2018 Jan 9;49(1):1. (PMID: 29316972)
      Front Cell Infect Microbiol. 2016 Oct 07;6:118. (PMID: 27774436)
      Microb Pathog. 2017 May;106:60-64. (PMID: 27816682)
      Vet Res Commun. 2003 Oct;27(7):513-26. (PMID: 14609263)
      Vet Microbiol. 1996 Jul;51(1-2):125-36. (PMID: 8828129)
      Genome Announc. 2013 Oct 31;1(6):null. (PMID: 24179118)
      Virulence. 2017 Aug 18;8(6):1031-1035. (PMID: 27689249)
      PLoS One. 2009 Jul 15;4(7):e6072. (PMID: 19603075)
      J Sci Food Agric. 2015 May;95(7):1454-60. (PMID: 25060787)
      PLoS One. 2012;7(9):e44449. (PMID: 22970221)
      Front Immunol. 2018 Nov 13;9:2615. (PMID: 30555459)
      J Bacteriol. 2011 May;193(9):2375-6. (PMID: 21398551)
      Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
      J Bacteriol. 2011 Jul;193(13):3428-9. (PMID: 21572001)
      Antimicrob Agents Chemother. 2010 Sep;54(9):3895-906. (PMID: 20606066)
      FEMS Microbiol Lett. 2003 Mar 14;220(1):113-9. (PMID: 12644236)
      Gene. 2014 Feb 10;535(2):156-64. (PMID: 24316490)
      Mol Microbiol. 2003 Aug;49(4):1135-44. (PMID: 12890034)
      Future Microbiol. 2019 Feb;14:207-222. (PMID: 30663887)
      J Biol Chem. 2001 Sep 14;276(37):34824-31. (PMID: 11448966)
      Vet Microbiol. 2008 Dec 10;132(3-4):340-7. (PMID: 18676101)
      Genome Announc. 2014 Aug 14;2(4):null. (PMID: 25125641)
    • Grant Information:
      BK20191309 Natural Science Foundation of Jiangsu Province; G2016060201 Shanghai Agriculture Applied Technology Development Program; 0 Priority Academic Program Development of Jiangsu Higher Education Institutions
    • Contributed Indexing:
      Keywords: Bacitracin; Efflux pump; Serotype Chz; SstFEG; Streptococcus suis; Virulence
    • Accession Number:
      0 (Anti-Bacterial Agents)
      0 (Anti-Infective Agents, Local)
      0 (Bacterial Proteins)
      0 (Membrane Transport Proteins)
      1405-87-4 (Bacitracin)
    • Publication Date:
      Date Created: 20191030 Date Completed: 20200313 Latest Revision: 20200313
    • Publication Date:
      20221213
    • Accession Number:
      PMC6819616
    • Accession Number:
      10.1186/s12917-019-2115-2
    • Accession Number:
      31660968